Genetic Study of the Dilatations of the Idiopathic Bronchi in French Polynesia

August 13, 2024 updated by: Centre Hospitalier Intercommunal Creteil

Etude génétique Des Dilatations Des Bronches Idiopathiques en Polynésie française

Bronchiectasis, defined by an increase in bronchial caliber and thickening of the bronchial wall, is associated with recurrent respiratory infections, chronic cough and bronchorrhea, and a frequent progression to chronic respiratory failure. Investigator distinguish focal bronchiectasis usually resulting from a localized cause and diffuse bronchiectasis which the possible causes are multiple (immune deficiencies, genetic diseases, auto immune pathologies, aspergillosis broncho -allergic lung, sequelae of pulmonary infections).The etiological assessment is negative in 26 to 53% of cases, defining the idiopathic bronchiectasis. However, the discovery of an underlying cause can change the patient's management (up to 37% of cases).

Despite the lack of epidemiological data in French Polynesia, Australian and New Zealand studies found a high prevalence of bronchiectasis in Polynesians. Few clinical studies published in the early 1980s suggested a ciliary origin.

Due to its geographic characteristics, the Polynesian population constitutes an interesting ethnic group. Indeed, there is a low genetic mixing and the prevalence of certain genetic diseases like the syndrome of Alport or some hereditary retinal dystrophies are high. This type of population is very suitable for discovering new genes in human pathology.

Investigator decided to conduct an observational study to find an underlying genetic cause of bronchiectasis in Polynesians by performing a whole exome sequencing. Investigator chose to study index cases defined by an upset of symptoms during the childhood, a family history of idiopathic bronchiectasis, and/or a consanguinity. Investigator also want to study healthy first degree relatives, in order to be able to better identify the clinical significant of DNA variants and focus the analysis on those that may be pathogenic

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Polynesian patient with dilatation of idiopathic bronchi

Description

*Patients

Inclusion Criteria:

  • Polynesian adult more than18 years
  • dilatation of idiopathic bronchi confirmed to thoracic CTscan
  • Negative etiological balance (including sweat test, research of Dyskinesia Ciliary Primitive and immunological check-up)
  • Appearance of symptoms in childhood, or family history of chronic bronchial disease, or notion of inbreeding
  • Signed consent
  • Affiliated with a social security system

Exclusion Criteria:

  • Refusal to participate in the study

    *Relatives

  • First-degree healthy relatives
  • Polynesian adult more than 18 years
  • Signed consent
  • Affiliated with a social security system

Exclusion Criteria:

  • Refusal to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Polynesian patient
Patient with dilatation of idiopathic bronchi
Blood analysis
Relatives of polynesian patient
Healthy
Blood analysis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
identification of genetic mutation
Time Frame: Anytime in the period of 10 years
New mutation in the coding region or mutation located outside the coding regions on the transcriptome
Anytime in the period of 10 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical phenotype
Time Frame: Anytime in the period of 10 years
Extra-respiratory history Bronchial colonizations Scannographic aspect
Anytime in the period of 10 years
scannographic description
Time Frame: Anytime in the period of 10 years
Extra-respiratory history Bronchial colonizations Scannographic aspect
Anytime in the period of 10 years
Effect on the splicing of messenger RNA
Time Frame: Anytime in the period of 10 years
correlation genotype/phenotype
Anytime in the period of 10 years
transcriptome of patients
Time Frame: Anytime in the period of 10 years
correlation genotype/phenotype
Anytime in the period of 10 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 10, 2022

Primary Completion (Actual)

March 8, 2022

Study Completion (Actual)

August 8, 2024

Study Registration Dates

First Submitted

May 26, 2020

First Submitted That Met QC Criteria

June 2, 2020

First Posted (Actual)

June 5, 2020

Study Record Updates

Last Update Posted (Actual)

August 14, 2024

Last Update Submitted That Met QC Criteria

August 13, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • POLYGENET

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Idiopathic Bronchiectasis

Clinical Trials on Blood Test

Subscribe